Following the MUGA scan, the physician documents the patient has developed chf as an adverse affect of the trastuzumab she received as a treatment for her breast ca. The trastuzumba antineoplastic antibiotic therapy is being discontinued while he attempts to manage the heart failure pharmaceutically. Code the patients condition.
A 428.0 96007 V10.3 E930.7
B 428.0 963.1 174.9 E 930.7
C 428.0 174.9 E930.7
D 428.0 174.9 E933.1
A 428.0 96007 V10.3 E930.7
B 428.0 963.1 174.9 E 930.7
C 428.0 174.9 E930.7
D 428.0 174.9 E933.1